Emirates Pharmaceutical Company approves the innovative “Etkamah” to treat breast cancer associated with ESR1 mutation
⚡ Quick Summary
Emirates Pharmaceutical Company approves the innovative “Etkamah” to treat breast cancer associated with ESR1 mutation